Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Keflex 250mg/5ml oral suspension
0501021L0BCAFAD
|
Keflex | Cefalexin | Infections | No data available |
|
Keflex 500mg capsules
0501021L0BCABAB
|
Keflex | Cefalexin | Infections | No data available |
|
Keftid 125mg/5ml oral suspension
0501021A0BDACAJ
|
Keftid | Cefaclor | Infections | No data available |
|
Keftid 250mg capsules
0501021A0BDAAAA
|
Keftid | Cefaclor | Infections | No data available |
|
Keftid 250mg/5ml oral suspension
0501021A0BDADAK
|
Keftid | Cefaclor | Infections | No data available |
|
Keftid 500mg capsules
0501021A0BDABAE
|
Keftid | Cefaclor | Infections | No data available |
|
Kefzol 1g powder for solution for injection vials
0501020V0BBABAB
|
Kefzol | Cefazolin sodium | Infections | No data available |
|
Kefzol 500mg powder for solution for injection vials
0501020V0BBAAAA
|
Kefzol | Cefazolin sodium | Infections | No data available |
|
Kemicetine 1g powder for solution for injection vials
0501070F0BCAAAC
|
Kemicetine | Chloramphenicol | Infections | No data available |
|
Kerymax 250mg gastro-resistant capsules
0501050C0BLAAAK
|
Kerymax | Erythromycin | Infections | No data available |
|
Ketek 400mg tablets
0501050T0BBAAAA
|
Ketek | Telithromycin | Infections | No data available |
|
Ketoconazole 100mg/5ml oral suspension
0502020A0AAADAD
|
Ketoconazole (Systemic) | Ketoconazole | Infections | No data available |
|
Ketoconazole 60mg/5ml oral suspension
0502020A0AAAEAE
|
Ketoconazole (Systemic) | Ketoconazole | Infections | No data available |
|
Ketoconazole 75mg/5ml oral suspension
0502020A0AAAFAF
|
Ketoconazole (Systemic) | Ketoconazole | Infections | No data available |
|
Klaricid 250mg tablets
0501050B0BBAAAA
|
Klaricid | Clarithromycin | Infections | No data available |
|
Klaricid 500 tablets
0501050B0BBADAD
|
Klaricid | Clarithromycin | Infections | No data available |
|
Klaricid IV 500mg powder for solution for infusion vials
0501050B0BBACAC
|
Klaricid | Clarithromycin | Infections | No data available |
|
Klaricid Paediatric 125mg granules sachets
0501050B0BBAGAG
|
Klaricid | Clarithromycin | Infections | No data available |
|
Ladropen 250mg capsules
0501012G0BCAAAA
|
Ladropen | Flucloxacillin sodium | Infections | No data available |
|
Ladropen 500mg capsules
0501012G0BCABAB
|
Ladropen | Flucloxacillin sodium | Infections | No data available |
|
Lamivudine 25mg/5ml oral solution
0503010Q0AAACAC
|
Lamivudine | Lamivudine | Infections | No data available |
|
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets
0503010AVAAAAAA
|
Lamivudine/tenofovir disoproxil | Lamivudine/tenofovir disoproxil | Infections | No data available |
|
Lamprene 100mg capsules
0501100C0BBAAAA
|
Lamprene | Clofazimine | Infections | No data available |
|
Lamprene 50mg capsules
0501100C0BBACAC
|
Lamprene | Clofazimine | Infections | No data available |
|
Lederkyn 500mg tablets
0501080T0BBAAAA
|
Lederkyn | Sulfamethoxypyridazine | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.